MedTrace Logo

Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care

NCT03276260 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2020-03-11

No results posted yet for this study

Summary

Medasense's Pain Monitoring Device (PMD) is a novel non-invasive, bedside stand alone, continuous monitor that is designed to provide real-time information about changes in the nociception level of patients under general anesthesia during surgical procedures.

The PMD-200 System is based on real-time data acquisition and processing of physiological signals. The system displays the NOL index (a single numerical index) which is computed from recorded physiological parameters based on a proprietary algorithm.

Conditions

  • Surgery
  • Nociceptive Pain
  • Postoperative Pain

Interventions

DEVICE

PMD-200

Patient will be connected to PMD-200 by finger-probe before induction of anesthesia or sedation. Recording will continue during surgery until extubation or awakening. Recording will be initiated again as soon as the patient arrives to the PACU until discharge to the surgical ward or home.

Sponsors & Collaborators

  • Medasense Biometrics Ltd

    lead OTHER

Principal Investigators

  • Ruth Edry, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276260 on ClinicalTrials.gov